METHODS: We included patients with painful shoulder attending our outpatient clinic for shoulder complains with the diagnosis of SACB with a bursal wall > 1.5 mm. A group was treated via US-guided hydrodilation, while the control group was treated via a classical blind approach using triamcinolone acetonide. Both groups underwent the same rehabilitation program following the injections. The shoulder functionality was assessed via qDASH questionnaire at baseline, days 3, 7, 14, 30, 60, and 90. A p <0.05 was considered significant.
RESULTS: Both groups displayed a significant reduction of pain; nevertheless, in the group treated with US-hydrodilation, there was no need for re-treatment.
CONCLUSIONS: The US-guided hydrodilation for SACB should be the preferred technique to detach bursal walls and improve patient symptoms, since it requires fewer invasive maneuvers.
方法:我们纳入了在我们的门诊就诊的肩部疼痛患者,这些患者的肩部抱怨诊断为法氏囊壁>1.5mm的SACB。一组通过US引导的加氢扩张治疗,而对照组则通过经典的盲法使用曲安奈德进行治疗。两组在注射后接受相同的康复计划。在基线时通过qDASH问卷评估肩部功能,第3、7、14、30、60和90天。P<0.05被认为是显著的。
结果:两组均显示疼痛明显减轻;尽管如此,在接受US-加氢扩张治疗的组中,没有必要再治疗。
结论:美国指导的SACB加氢扩张应该是分离法氏囊壁和改善患者症状的首选技术,因为它需要更少的侵入性操作。